Skip to main content

Table 1 Clinicopathological characteristics of patients with breast cancer

From: Short-term serial assessment of electronic patient-reported outcome for depression and anxiety in breast Cancer

Ā 

nā€‰=ā€‰137

Age (meanā€‰Ā±ā€‰SD, years)

53.83ā€‰Ā±ā€‰11.60

Body mass index (meanā€‰Ā±ā€‰SD, kg/m2)

24.82ā€‰Ā±ā€‰7.25

Age of menarche (meanā€‰Ā±ā€‰SD, years)

18.81ā€‰Ā±ā€‰0.71

Postmenopausal status

65 (47.45)

Marital status

ā€ƒMarried

106 (77.37)

ā€ƒSingle

25 (18.25)

ā€ƒDivorced

6 (4.38)

Number of children

ā€ƒ0

16 (11.68)

ā€ƒ1

18 (13.14)

ā€ƒ2

73 (53.28)

ā€ƒā€‰>ā€‰3

30 (21.90)

Family history of breast or ovarian cancer

6 (4.38)

History of hormone replacement therapy

ā€ƒNo

134 (97.81)

ā€ƒYes

3 (2.19)

Location of tumor

ā€ƒRight

76 (55.48)

ā€ƒLeft

61 (44.53)

Types of tumor

ā€ƒDuctal carcinoma in situ

21 (15.33)

ā€ƒInvasive ductal carcinoma

112 (81.76)

ā€ƒInvasive lobular carcinoma

1 (0.73)

ā€ƒOther

3 (2.19)

Pathologic stage

ā€ƒ0

22 (16.06)

ā€ƒIA

66 (48.18)

ā€ƒIIA

25 (18.25)

ā€ƒIIB

15 (10.95)

ā€ƒIIIA

7 (5.11)

ā€ƒIIIC

2 (1.46)

Estrogen receptor

ā€ƒPositive

119 (86.87)

ā€ƒNegative

18 (13.14)

Progesterone receptor

ā€ƒPositive

102 (74.46)

ā€ƒNegative

35 (25.55)

Her2/neu gene

ā€ƒPositive

24 (17.52)

ā€ƒNegative

113 (82.49)

Triple negative breast cancer

17 (12.41)

Ki67 index

ā€ƒā€‰ā‰„ā€‰15%

100 (73.00)

ā€ƒā€‰<ā€‰15%

37 (27.01)

Type of breast surgery

ā€ƒBreast conserving surgery

98 (71.54)

ā€ƒMastectomy

39 (28.47)

ā€ƒBreast reconstruction

42 (30.66)

Type of axillary surgery

ā€ƒNo operation

4 (2.92)

ā€ƒSentinel lymph nodes biopsy

119 (86.87)

ā€ƒAxillary lymph nodes dissection

14 (10.22)

Adjuvant chemotherapy

62 (45.26)

Adjuvant radiotherapy

97 (70.81)

Adjuvant hormonal therapy

93 (67.89)

Follow-up period (meanā€‰Ā±ā€‰SD, months)

8.01ā€‰Ā±ā€‰0.69

  1. *Data are expressed as n, %